Evolent Health, Inc.
EVH
$2.99
-$0.07-2.29%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.26% | 7.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.26% | 7.92% | |||
| Cost of Revenue | -2.18% | 10.41% | |||
| Gross Profit | -2.53% | -0.61% | |||
| SG&A Expenses | -18.07% | 1.46% | |||
| Depreciation & Amortization | 90.71% | 2.05% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.11% | 8.46% | |||
| Operating Income | -1,565.05% | -76.72% | |||
| Income Before Tax | -2,058.57% | 3.69% | |||
| Income Tax Expenses | -285.10% | 209.82% | |||
| Earnings from Continuing Operations | -1,956.80% | -4.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,956.80% | -4.86% | |||
| EBIT | -1,565.05% | -76.72% | |||
| EBITDA | 59.04% | -8.32% | |||
| EPS Basic | -1,444.94% | 46.45% | |||
| Normalized Basic EPS | -97.88% | -92.09% | |||
| EPS Diluted | -1,444.94% | 46.45% | |||
| Normalized Diluted EPS | -97.88% | -92.09% | |||
| Average Basic Shares Outstanding | -2.15% | -1.57% | |||
| Average Diluted Shares Outstanding | -2.15% | -1.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 1.00% | 0.60% | |||